Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 81 | 2025 | 273 | 17.760 |
Why?
|
| Knee Joint | 53 | 2025 | 172 | 7.340 |
Why?
|
| Osteoarthritis | 11 | 2024 | 103 | 4.080 |
Why?
|
| Disease Progression | 33 | 2024 | 2224 | 2.240 |
Why?
|
| Arthralgia | 9 | 2024 | 68 | 2.090 |
Why?
|
| Tibia | 14 | 2023 | 80 | 2.080 |
Why?
|
| Radiography | 25 | 2025 | 818 | 2.060 |
Why?
|
| Bone Density | 8 | 2018 | 369 | 1.700 |
Why?
|
| Running | 3 | 2018 | 33 | 1.660 |
Why?
|
| Cartilage, Articular | 13 | 2023 | 64 | 1.620 |
Why?
|
| Exercise | 7 | 2025 | 859 | 1.390 |
Why?
|
| Bone Marrow | 12 | 2020 | 332 | 1.320 |
Why?
|
| Magnetic Resonance Imaging | 39 | 2023 | 3854 | 1.240 |
Why?
|
| Pain | 10 | 2024 | 462 | 1.190 |
Why?
|
| Gardening | 2 | 2025 | 17 | 1.170 |
Why?
|
| Middle Aged | 69 | 2025 | 28922 | 1.110 |
Why?
|
| Aged | 58 | 2025 | 21404 | 1.100 |
Why?
|
| Longitudinal Studies | 20 | 2023 | 1494 | 1.060 |
Why?
|
| Knee Injuries | 9 | 2023 | 41 | 1.060 |
Why?
|
| Arthroplasty, Replacement, Knee | 7 | 2023 | 153 | 0.980 |
Why?
|
| Cross-Sectional Studies | 17 | 2025 | 3738 | 0.970 |
Why?
|
| Synovitis | 7 | 2022 | 26 | 0.930 |
Why?
|
| Pain Measurement | 13 | 2019 | 351 | 0.910 |
Why?
|
| Bicycling | 1 | 2024 | 35 | 0.850 |
Why?
|
| Weight-Bearing | 7 | 2016 | 44 | 0.840 |
Why?
|
| Exercise Therapy | 2 | 2024 | 184 | 0.830 |
Why?
|
| Resistance Training | 1 | 2023 | 32 | 0.830 |
Why?
|
| Walking | 5 | 2022 | 232 | 0.820 |
Why?
|
| Menisci, Tibial | 7 | 2023 | 38 | 0.820 |
Why?
|
| Humans | 100 | 2025 | 132083 | 0.770 |
Why?
|
| Male | 75 | 2025 | 64904 | 0.770 |
Why?
|
| Femur | 6 | 2023 | 74 | 0.750 |
Why?
|
| Methotrexate | 1 | 2024 | 351 | 0.740 |
Why?
|
| Female | 75 | 2025 | 70664 | 0.690 |
Why?
|
| Swimming | 1 | 2019 | 29 | 0.640 |
Why?
|
| Football | 1 | 2020 | 36 | 0.640 |
Why?
|
| Tibial Meniscus Injuries | 4 | 2019 | 31 | 0.600 |
Why?
|
| Chronic Pain | 1 | 2021 | 148 | 0.600 |
Why?
|
| Severity of Illness Index | 15 | 2024 | 3083 | 0.570 |
Why?
|
| Cancellous Bone | 1 | 2018 | 8 | 0.570 |
Why?
|
| Physicians | 1 | 2024 | 637 | 0.530 |
Why?
|
| Bone Malalignment | 2 | 2016 | 4 | 0.520 |
Why?
|
| Logistic Models | 10 | 2025 | 1838 | 0.500 |
Why?
|
| Knee | 2 | 2015 | 22 | 0.500 |
Why?
|
| Osteoarthritis, Hip | 3 | 2023 | 61 | 0.480 |
Why?
|
| Absorptiometry, Photon | 6 | 2018 | 204 | 0.470 |
Why?
|
| Risk Factors | 23 | 2023 | 10899 | 0.470 |
Why?
|
| Motor Activity | 2 | 2015 | 521 | 0.450 |
Why?
|
| Bone Marrow Diseases | 3 | 2011 | 41 | 0.450 |
Why?
|
| Quality of Life | 1 | 2024 | 2152 | 0.440 |
Why?
|
| Hand Joints | 2 | 2024 | 6 | 0.410 |
Why?
|
| Pain Management | 3 | 2019 | 199 | 0.390 |
Why?
|
| Body Mass Index | 11 | 2020 | 1699 | 0.370 |
Why?
|
| Blood Pressure | 1 | 2017 | 1396 | 0.360 |
Why?
|
| Cartilage Diseases | 2 | 2022 | 15 | 0.340 |
Why?
|
| Analgesics | 2 | 2009 | 126 | 0.340 |
Why?
|
| Cohort Studies | 8 | 2024 | 5148 | 0.300 |
Why?
|
| Joint Instability | 2 | 2019 | 59 | 0.300 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17367 | 0.290 |
Why?
|
| Hypertension | 1 | 2017 | 1387 | 0.290 |
Why?
|
| Prospective Studies | 6 | 2023 | 6530 | 0.280 |
Why?
|
| Prevalence | 3 | 2025 | 2657 | 0.280 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 3982 | 0.260 |
Why?
|
| United States | 9 | 2020 | 11630 | 0.260 |
Why?
|
| Symptom Assessment | 2 | 2018 | 109 | 0.250 |
Why?
|
| Vasculitis | 1 | 2006 | 50 | 0.250 |
Why?
|
| Time Factors | 10 | 2019 | 6445 | 0.250 |
Why?
|
| Biomechanical Phenomena | 3 | 2017 | 261 | 0.240 |
Why?
|
| Incidence | 6 | 2022 | 3365 | 0.230 |
Why?
|
| Life Style | 1 | 2008 | 452 | 0.230 |
Why?
|
| Patient Education as Topic | 2 | 2024 | 461 | 0.230 |
Why?
|
| Denmark | 1 | 2024 | 29 | 0.220 |
Why?
|
| Case-Control Studies | 10 | 2023 | 3417 | 0.220 |
Why?
|
| Prognosis | 7 | 2023 | 5006 | 0.220 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 248 | 0.210 |
Why?
|
| Skin | 1 | 2006 | 538 | 0.210 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 109 | 0.200 |
Why?
|
| Risk Assessment | 4 | 2019 | 3714 | 0.190 |
Why?
|
| Antirheumatic Agents | 1 | 2024 | 122 | 0.190 |
Why?
|
| Walking Speed | 2 | 2020 | 18 | 0.190 |
Why?
|
| Carpometacarpal Joints | 1 | 2022 | 2 | 0.190 |
Why?
|
| Chiroptera | 1 | 2022 | 18 | 0.190 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 413 | 0.190 |
Why?
|
| Anterior Cruciate Ligament | 2 | 2019 | 11 | 0.180 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 214 | 0.180 |
Why?
|
| Linear Models | 3 | 2018 | 710 | 0.180 |
Why?
|
| Adult | 10 | 2024 | 31544 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2024 | 473 | 0.170 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 261 | 0.170 |
Why?
|
| Reproducibility of Results | 6 | 2018 | 3020 | 0.160 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2021 | 94 | 0.160 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ligaments, Articular | 1 | 2019 | 22 | 0.160 |
Why?
|
| Synovial Membrane | 1 | 2019 | 26 | 0.150 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 5399 | 0.150 |
Why?
|
| Rheumatology | 1 | 2020 | 129 | 0.150 |
Why?
|
| Arthrography | 1 | 2018 | 6 | 0.140 |
Why?
|
| X-Rays | 1 | 2018 | 31 | 0.140 |
Why?
|
| Sound | 1 | 2017 | 22 | 0.140 |
Why?
|
| Iodine | 1 | 2017 | 24 | 0.140 |
Why?
|
| Radiographic Image Enhancement | 1 | 2017 | 45 | 0.140 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2017 | 5 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2019 | 391 | 0.130 |
Why?
|
| Systole | 1 | 2017 | 203 | 0.130 |
Why?
|
| Meniscus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Homeostasis | 2 | 2018 | 723 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 211 | 0.130 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 2007 | 34 | 0.120 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 17 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 471 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2019 | 511 | 0.120 |
Why?
|
| Musculoskeletal Pain | 1 | 2015 | 16 | 0.120 |
Why?
|
| Mammography | 1 | 2016 | 133 | 0.120 |
Why?
|
| Vitamin D | 2 | 2014 | 180 | 0.110 |
Why?
|
| Venous Thrombosis | 2 | 2007 | 170 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 422 | 0.110 |
Why?
|
| Odds Ratio | 3 | 2020 | 1255 | 0.100 |
Why?
|
| Contrast Media | 1 | 2017 | 508 | 0.100 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 74 | 0.100 |
Why?
|
| Age Factors | 5 | 2020 | 2922 | 0.100 |
Why?
|
| Glucose | 1 | 2018 | 878 | 0.100 |
Why?
|
| Cartilage | 1 | 2013 | 51 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 383 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 1038 | 0.100 |
Why?
|
| Hand | 2 | 2024 | 107 | 0.100 |
Why?
|
| Disability Evaluation | 2 | 2015 | 194 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2017 | 1121 | 0.100 |
Why?
|
| Vitamins | 1 | 2013 | 111 | 0.100 |
Why?
|
| Phenotype | 1 | 2022 | 4541 | 0.090 |
Why?
|
| Hyaline Cartilage | 1 | 2011 | 2 | 0.090 |
Why?
|
| Body Weight | 1 | 2016 | 993 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2168 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2021 | 13014 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2011 | 29 | 0.080 |
Why?
|
| Algorithms | 1 | 2017 | 1724 | 0.080 |
Why?
|
| Young Adult | 2 | 2024 | 9935 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2017 | 1386 | 0.080 |
Why?
|
| Orthotic Devices | 1 | 2009 | 21 | 0.070 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 48 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2008 | 57 | 0.070 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2007 | 4 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2009 | 75 | 0.070 |
Why?
|
| Weight Loss | 1 | 2012 | 515 | 0.070 |
Why?
|
| Thrombophilia | 1 | 2007 | 41 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 1246 | 0.070 |
Why?
|
| Cefazolin | 1 | 2006 | 20 | 0.060 |
Why?
|
| Arterioles | 1 | 2006 | 40 | 0.060 |
Why?
|
| Delphi Technique | 2 | 2023 | 240 | 0.060 |
Why?
|
| Osteosclerosis | 1 | 2006 | 12 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 189 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2008 | 1226 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 669 | 0.060 |
Why?
|
| Self Report | 2 | 2020 | 553 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1295 | 0.060 |
Why?
|
| Injections, Intra-Articular | 1 | 2003 | 33 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2016 | 81 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2682 | 0.050 |
Why?
|
| Child | 2 | 2022 | 25761 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 297 | 0.050 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2022 | 8 | 0.050 |
Why?
|
| Counseling | 1 | 2024 | 233 | 0.050 |
Why?
|
| Thumb | 1 | 2022 | 30 | 0.050 |
Why?
|
| Observer Variation | 2 | 2014 | 307 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 1306 | 0.050 |
Why?
|
| Androstenes | 1 | 2021 | 7 | 0.040 |
Why?
|
| Phenylthiohydantoin | 1 | 2021 | 15 | 0.040 |
Why?
|
| Diet | 1 | 2008 | 1124 | 0.040 |
Why?
|
| Adolescent | 1 | 2019 | 20532 | 0.040 |
Why?
|
| Taxoids | 1 | 2021 | 71 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 7119 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2022 | 188 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 124 | 0.040 |
Why?
|
| Prednisone | 1 | 2021 | 252 | 0.040 |
Why?
|
| Nitriles | 1 | 2021 | 155 | 0.040 |
Why?
|
| London | 1 | 2020 | 15 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2021 | 133 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 2303 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2394 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2024 | 569 | 0.040 |
Why?
|
| Consensus | 1 | 2023 | 656 | 0.040 |
Why?
|
| Gait | 1 | 2020 | 140 | 0.040 |
Why?
|
| Accelerometry | 1 | 2019 | 64 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 1158 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 704 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 761 | 0.040 |
Why?
|
| Exercise Test | 1 | 2019 | 256 | 0.040 |
Why?
|
| Random Allocation | 1 | 2019 | 432 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 545 | 0.030 |
Why?
|
| Fatigue | 1 | 2019 | 198 | 0.030 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2017 | 10 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 897 | 0.030 |
Why?
|
| Hong Kong | 1 | 2016 | 15 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2013 | 1653 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 482 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 194 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 598 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2553 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 81 | 0.030 |
Why?
|
| Protein Precursors | 2 | 1992 | 156 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 2141 | 0.030 |
Why?
|
| Cadaver | 1 | 2014 | 119 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 390 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1347 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 447 | 0.020 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 1992 | 19 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 237 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 1002 | 0.020 |
Why?
|
| Osteophyte | 1 | 2011 | 7 | 0.020 |
Why?
|
| Prothrombin | 1 | 1991 | 26 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 827 | 0.020 |
Why?
|
| Ligaments | 1 | 2011 | 21 | 0.020 |
Why?
|
| Wrist Joint | 1 | 2011 | 28 | 0.020 |
Why?
|
| Tendons | 1 | 2011 | 37 | 0.020 |
Why?
|
| Boston | 1 | 2011 | 122 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1521 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1351 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 1801 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 587 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2013 | 439 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 796 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2013 | 1228 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 1762 | 0.020 |
Why?
|
| DNA | 1 | 1992 | 1483 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 1991 | 1683 | 0.010 |
Why?
|
| Animals | 2 | 2022 | 34951 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1991 | 987 | 0.010 |
Why?
|
| Biomarkers | 1 | 1991 | 3377 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3358 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 6248 | 0.010 |
Why?
|
| Jejunum | 1 | 1992 | 131 | 0.010 |
Why?
|
| Duodenum | 1 | 1992 | 113 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1992 | 329 | 0.010 |
Why?
|
| Pancreas | 1 | 1992 | 222 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 813 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1991 | 134 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1991 | 171 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2674 | 0.000 |
Why?
|
| Base Sequence | 1 | 1992 | 2902 | 0.000 |
Why?
|
| Gene Expression | 1 | 1992 | 1564 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 3778 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1992 | 2679 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1991 | 989 | 0.000 |
Why?
|
| Rats | 1 | 1992 | 3612 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1991 | 898 | 0.000 |
Why?
|